Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) cultures

Anti-Cancer Drugs

Volumn 7, Issue 6, 1996, Pages 660-670

  Griffon Etienne, Geneviève ^a,b   Merlin, Jean Louis ^a   Marchai, Christian ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Docetaxel; Irradiation; Multicellular tumor spheroid; Ovarian tumor; Paclitaxel; Sulforhodamine B

Indexed keywords

DOCETAXEL; PACLITAXEL; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CELL CULTURE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SPHEROID;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0029985157     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199608000-00007     Document Type: Article

References (39)

1. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971; 93: 2325-7.
2. Bissery MC, Guenard D, Gueritte-Voegelein F, Lavelle F. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Res 1991; 51: 4845-52.
3. Gueritte-Voegelein F, Guenard D, Lavelle F, Le Goff MT, Mangatal L, Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 1991; 34: 992-8.
4. Ringel I, Horwitz SB Studies with RP 56976 (taxotere): a semisynthetic analogue of Taxol. J Natl Cancer Inst 1991; 83: 288-91.
5. Kelland LR, Abel G. Comparative in vitro cytotoxicity of taxol and taxotere against cisplatin-sensitive and - resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1992; 30: 444-50.
6. R): a review of preclinical and clinical experience. Part I: preclinical experience. Anti-Cancer Drugs 1995; 6: 339-68.
7. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-7.
8. Coleman CN. Review article. Beneficial liasions: radiobiology meets cellular and molecular biology. Radiother Oncol 1993; 28: 1-15.
9. McGuire WP, Rowinsky EK. Old drugs revisited, new drugs, and experimental approaches in ovarian cancer therapy. Semin Oncol 1991; 18: 255.
10. Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 1994; 54: 3506-10.
11. Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. In vitro studies of taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994; 86: 441-6.
12. R). Int J Radiat Oncol Biol Phys 1994; 29: 559-64.
13. Steren A, Sevin BU, Perras J, et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993; 48: 252-8.
14. Choy H, Rodriguez F, Wilcox B, Koester SK, Degen D, Radiation sensitizing effects of Taxotere. Proc Am Ass Cancer Res 1992; 33: 500.
15. Stromberg JS, Lee YJ, Armour EP, Martinez AA, Corry PM. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer 1995; 75: 2262-8.
16. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992; 52: 3495-7.
17. Geard CR, Jones JM. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994; 29: 565-9.
18. Skehan P, Storeng P, Scudeiro D, et al. New colorimetric cytotoxicity assay for anti-cancer drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
19. Griffon G, Merlin JL, Marchai C. Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines. Anti-Cancer Drugs 1995; 6: 115-23.
20. Keepers PY, Pizao PE, Peters GJ, Van Ark-Otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 1991; 7: 897-900.
21. Griffon G, Marchai C, Merlin JL, Marchai S, Parache RM, Bey P. Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers Eur J Cancer 1995; 31A: 85-91.
22. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 1988; 240: 177-84.
23. Griffon G, Merlin JL, Parache RM, et al. Sensitivity to taxoid derivatives of a newly established human endometrioid ovarian adenocarcinoma radioresistant cell line. Anticancer Res 1996; 16: 177-88
24. Fertil B, Malaise EP. Inherent cellular radiation as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 1981; 7: 621-9.
25. Chou TC, Talalay P. Quantitative analysis of dose effect relationship: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
26. Yuhas JM, Li AP, Martinez AO, Landman AJ. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 1977; 37: 3639-43.
27. Schwachöfer JHM, Crooijmans RPMA, Hoogenhout J, Jerusalem CR, Kal HB, Theeuwes AGM. Radiosensitivity of different human tumor cell lines grown as multicellular spheroids derived from growth curves and survival data. Int J Radiat Oncol Biol Phys 1989; 17: 1015-20.
28. Stuschke M, Budach V, Budach W, Feldamann HJ, Sack H. Radioresponsiveness, sublethal damage repair and stem cell rate in spheroids from three human tumor lines: comparison with xenograft data. Int J Radiat Oncol Biol Phys 1992; 24: 119-26.
29. Steel GG, Peckham MJ. Exploitable mechanisms for combined radiotherapy chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979; 5: 85-91.
30. Merlin JL. Concepts of synergism and antagonism. Anticancer Res 1994; 14: 2312-5.
31. Tishler RB, Schiff PB, Geard CR, Hall EJ. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 1992; 22: 613-7.
32. Geard CR, Jones JM. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994; 29: 565-9.
33. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995; 55: 3564-8.
34. Gillespie CJ, Chapman JD, Reuvers AP, Dugle DL. The inactivation of Chinese hamster cells by X rays: synchronized and exponential cell populations. Radiat Res 1975; 64: 353-64.
35. Minarik L, Hall EJ. Taxol in combination with acute and low dose rate irradiation. Radiother Oncol 1994; 32: 124-8.
36. Durand RE. Distribution and activity of antineoplasic drugs in a tumor model. J Natl Cancer Inst 1989; 81: 146-152.
37. Erlanson M, Daniel-Szolgay E, Carlsson J. Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids. Cancer Chemother Pharmacol 1992; 29: 343-53.
38. West CML, Sutherland RM. The radiation response of a human colon adenocarcinoma grown in monolayers, as spheroids, and in nude mice. Radiat Res 1987; 112: 105-15.
39. Mueller-Klieser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 1987; 113: 113-22.